JPMorgan says large-cap biotech is back as profits and pipelines fuel upside Investing.com · 2026-05-28T20:27:17Z
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls The Fly · 2026-05-19T13:34:39Z
Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout Proactive · 2026-05-19T13:33:00Z
How Investors Are Reacting To Alnylam Pharmaceuticals (ALNY) New HELIOS-B Vutrisiran Data And Real-World Study Simply Wall St. · 2026-05-18T18:14:19Z
Alnylam’s Vutrisiran Data And Real-World Study Contrast With Depressed Valuation Simply Wall St. · 2026-05-18T08:05:05Z
Is Alnylam (ALNY) One of the Best Aggressive Growth Stocks to Buy? Insider Monkey · 2026-05-14T19:59:47Z
Alnylam Pharmaceuticals Backs TTR Outlook as AMVUTTRA Access, Prescriber Growth Build MarketBeat · 2026-05-13T20:14:37Z
Morgan Stanley Increases Price Goal on Alnylam Pharmaceuticals, Inc. (ALNY) Insider Monkey · 2026-05-13T17:55:45Z